Exclusion criteria included ventricular septal rupture, cardiac tamponade, severe valvular disease, isolated right ventricular CS, known dilated cardiomyopathy, shock from other causes (e.g ...
Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...
Baylor Scott & White The Heart Hospital-Plano in Texas cut times of cardiogenic shock diagnosis in half after implementing a quality improvement project that included nurse education and an ...
Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...
Medscape Medical News, September 08, 2024 ESC 2024 Managing Cardiogenic Shock & Cardiac Arrest: We'll Get There New analyses are improving understanding of cardiogenic shock heterogeneity ...
SCAI Stage C cardiogenic shock is characterized by significant ... in earlier studies by improving systolic blood pressure ...
Windtree Therapeutics (WINT) announced that Alexandre Mebazaa, MD, one of the world’s recognized leaders in cardiogenic shock, gave a ...
The FDA has opened up the use of Johnson & Johnson’s miniaturized heart pumps to certain pediatric patients, including those ...